Bioequivalence of domestic and imported carvedilol tablets

Li Xuening,Dai Peifang,Ge Qinghua,Zhou Zhen,Xu Hongrong,Zhi Xiaojin
DOI: https://doi.org/10.3969/j.issn.1007-4406.2006.01.010
2006-01-01
Abstract:AIM To study the bioequivalence of domestic and imported carvedilol tablets following a single oral dose of 25 mg given to 20 healthy male subjects in a randomized crossover design.METHODS Plasma concentrations were determined by HPLC-fluorescence.The pharmacokinetic parameters were calculated from 3P97 software.RESULTS The main pharmacokinetic parameters of domestic and imported tablets of carvedilol were as follows: ρ_(max):(50.46±26.25 )μg·L~(-1) and(61.74±36.00)μg·L~(-1);t_(max):(0.98±0.50) h and(1.13±0.67) h;AUC_(0→t):(171.6±79.39)μg·h·L~(-1) and(187.1±99.91)μg·h·L~(-1),respectively.The statistic analysis of the two formulations was calculated by analysis of variance,two one-sided t tests and confidence intervals. The results demonstrated that there were no significant differences between domestic and imported tablets(P>0.05).CONCLUSION The relative bioavailability of domestic tablets is(95.74±17.90)%(n=20).The domestic and imported tablets show bioequivalence.
What problem does this paper attempt to address?